Life Sciences SMEs Need Scale-Up Support – Immunocore CEO
Executive Summary
Eliot Forster has backed the Life Sciences Industrial Strategy's call for more patient capital in helping smaller biotechs fulfil their potential.
You may also be interested in...
Pharma Calls On UK Govt To Fund Centers of Excellence
The Medicines Manufacturing Industry Partnership says £140m invested in four centers would provide high-skilled jobs and make the UK the first place in the world where drugs can be discovered, made and packaged.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Pharma Firms Welcome 'Pragmatic' EU Reforms But Concerns Persist
The European parliament has voted for legislation it says will lead to fairer, more accessible healthcare. The continent's drugmakers are still not wholly convinced.